Bio-Rad Laboratories, Inc. BIO.B Share-based compensation expense related to employee stock plans

Share-based compensation expense related to employee stock plans at other companies

Thermo Fisher ScientificTMO

——

Charles River LaboratoriesCRL

——

GE HealthCare TechnologiesGEHC

——

ZoetisZTS

——

Other financials

Income statement

See full

Revenue$592.1M+1.1%

Gross profit$309.4M+1.1%

Operating income$34.1M+43.9%

Net income-$527.1M-924%

EPS (diluted)-$19.55-954%

Balance sheet

See full

Cash & equivalents$509.0M-2.7%

Total debt$987.3M-28.4%

Total equity$6.9B+2.6%

Total assets$9.8B+2.8%

Cash flow

See full

Operating cash flow$108.1M-16.8%

CapEx$30.0M-12.8%

Free cash flow$78.1M-18.2%

Valuation

See full

Market cap$7.56B+10.3%

Enterprise value$8.04B+4.2%

P/E44.8×—

P/S2.9×+0.2×

Profitability

See full

Gross margin51.9%-1.6pp

Operating margin8.8%-3.1pp

Net margin6.5%+3.4pp

FCF margin13.8%-0.2pp

Returns & leverage

See full

Return on equity2.5%+1.3pp

Debt / equity0.1×-0.1×

Current ratio3.2×-2.8×

Where this comes from

Reported directly by Bio-Rad Laboratories, Inc. in its filing.

Tagged under the XBRL concept us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue.

The official record: Bio-Rad Laboratories, Inc.’s 10-Q, filed April 30, 2026, on SEC EDGAR. View the filing →

Ask your AI about Bio-Rad Laboratories, Inc.'s share-based compensation expense related to employee stock plans.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is Bio-Rad Laboratories, Inc.'s share-based compensation expense related to employee stock plans?: Bio-Rad Laboratories, Inc. (BIO.B) reported share-based compensation expense related to employee stock plans of $15M in Q1 2026.
How has Bio-Rad Laboratories, Inc.'s share-based compensation expense related to employee stock plans changed year-over-year?: Bio-Rad Laboratories, Inc.'s share-based compensation expense related to employee stock plans decreased by 2.0% year-over-year, from $15.3M to $15M.